In vivo effects of phosphodiesterase III inhibitors on glucose metabolism and insulin sensitivity

Journal of the Chinese Medical Association

Volumn 66, Issue 4, 2003, Pages 210-216

  Yang, Gangyi ^a   Li, Ling ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Insulin clamping; Insulin resistance; Milrinone

Indexed keywords

AMPICILLIN; FATTY ACID; GLUCOSE; HEPARIN; INSULIN; MILRINONE; PENTOBARBITAL; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC AMP; PHOSPHODIESTERASE III;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE METABOLISM; HYPERINSULINEMIA; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INTERNAL JUGULAR VEIN; LIPOLYSIS; MALE; NONHUMAN; RADIOIMMUNOASSAY; RAT; STATISTICAL ANALYSIS; ANIMAL; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, NONESTERIFIED; GLUCOSE; INSULIN RESISTANCE; LIPOLYSIS; MALE; MILRINONE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0141631495     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Beavo JA, Conti M, Heaslip RJ. Multiple cyclic nucleotide phosphodiesterase. Mol Pharmacol 1994;46:399-405.
2. Bolger GB. Molecular biology of the cyclic AMP-specific cyclic uncleotide phosphodiesterases: a diverse family of regulatory enzymes. Cell Signaling 1994;6:851-9.
3. Germain N, Bertin B, Legendre A, Martin B, Lagente V, Payne A, Biochot E. Selective phosphodiesterase inhibitors modulate the activity of alveolar macrophages from sensitized guinea-pigs. Eur Respir J 1998;12:1334-9.
4. Malaisse WJ, Malaisse-Lagae F, Myhew D. A possitile role for the adenylcyclase system in insulin-secretion. J Clin Invest 1967;46:1724-34.
5. Furman BL, Pyne NJ. Islet phosphodiesterase enzymes and glucose-induced insulin secretion. Diabetic Med 1990;7: 19-22.
6. Shafiee-Nick R, Pyne NJ, Furman BL. Effects of type-specific phosphopcsterase inhibitors on insulin secretion from rat isolated islets. Diabetic Med 1993;10(suppl 1):48-52.
7. Peder JC, Vanvolkenburg MA, Kedhum RJ, Bmpman KL, Andrews KM. Cyclic AMP phosphodiestcrs of human and rat islets of langerhans: contributions of types III and IV to the modulation of insulin secretion. Biochem Biophys Res Commun 1997; 217:916-23.
8. Abdel-aleem S, Frangakis C. Stimulation of fatty acid oxidation by phosphodiesterase III inhibitors in rat myocytes. J Cardiovasc Pharmacol 1993;18:293-7.
9. Abdel-aleem S, Badr M, Frangakis C. Stimulation of fatty acid oxidation in myocytes by phosphodiesterase inhibitors and adenosine analogues. Life Sci 1991;48:PL97-102.
10. Dorigo P, Gaion RM, Maszethe S, Marcomini A, Maragmo I. Amrinone potentiates catechholamine-induced lipolysis in fat cells. Biochem Pharmacol 1989;38:855-8.
11. Parker JC, Van Volkenburg MA, Nardone NA, Hargrove DM, Andrews KM. Mediation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodicsterase III. Biochem Res Commun 1997;236:665-9.
12. Shaftee-Nick R, Pyne NJ, Furman BL. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phmphodicsforase activity. Brit J Pharmacol 1995;115:1486-92.
13. Leibowitz MD, Biswas C, Brady EJ, Conti M, Cullinan CA, Hayes NS, Berger J. A novel insulin secretagogue is a phosphodiesterase inhibitor. Diabetes 1995;44t:67-74.
14. Boden G. Fatty acids and insulin resistance. Diabetes Care 1996;19:394-5.
15. Fain JN. Hormonal regulation of lipid mobilization from adipose tissue. Biochem Act Horm 1980;7:119-204.
16. Abdel-aleem S, Awadi MK, Zarouk WA, Lowe JE. Effects of phosphodiesterase inhibitors on glucose utilization in isolated cardiac myocytes. Mol Cell Biochem 1998;180:129-35.
17. Chen X- Iqbal N, Beden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 1999;103:365-72.
18. Boden G. Free fatty acids (FFA), a link betwen obesity and insulin resistance. From Bio 1998;15:169-75.